Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
8/15/25 16:13 | 8/15/25 | LLY | Health | Drug | Pharmaceutical Preparations | Montarce Lucas | IN | O | EVP,CFO | P | 495 | 691.79 | 0 | 1 | 5 | 15 | D | ||||||||||||||
8/14/25 16:12 | 8/13/25 | LLY | Health | Drug | Pharmaceutical Preparations | Alvarez Ralph | IN | D | P | 500 | 660.25 | 0 | 1 | 1 | 56 | I | |||||||||||||||
8/13/25 16:15 | 8/13/25 | LLY | Health | Drug | Pharmaceutical Preparations | Van Naarden Jacob | IN | O | EVP,P,Li | P | 647 | 647.36 | 0 | 1 | 4 | 29 | D | ||||||||||||||
8/12/25 16:23 | 8/12/25 | LLY | Health | Drug | Pharmaceutical Preparations | Ricks David A | IN | DO | P,Chair, | P | 1,052 | 644.77 | 0 | 2 | 0 | 677 | D | ||||||||||||||
8/12/25 16:20 | 8/12/25 | LLY | Health | Drug | Pharmaceutical Preparations | Skovronsky Daniel | IN | O | EVP,CSO, | P | 634 | 634.41 | 0 | 1 | 0 | 213 | D | ||||||||||||||
8/12/25 16:19 | 8/12/25 | LLY | Health | Drug | Pharmaceutical Preparations | Sulzberger Gabrielle | IN | D | P | 75 | 641.18 | 0 | 0 | 5 | 3 | D | |||||||||||||||
8/12/25 16:17 | 8/12/25 | LLY | Health | Drug | Pharmaceutical Preparations | Fyrwald J Erik | IN | D | P | 1,005 | 642.33 | 0 | 2 | 2 | 75 | D | |||||||||||||||
8/8/25 16:20 | 8/8/25 | LLY | Health | Drug | Pharmaceutical Preparations | Jackson Jamere | IN | D | P | 128 | 639.56 | 0 | 0 | 2 | 9 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |